China Universal Asset Management Co., Ltd. Anavex Life Sciences Corp. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 17,980 shares of AVXL stock, worth $155,347. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,980
Previous 16,309
10.25%
Holding current value
$155,347
Previous $92,000
109.78%
% of portfolio
0.02%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding AVXL
# of Institutions
163Shares Held
26.6MCall Options Held
515KPut Options Held
838K-
Black Rock Inc. New York, NY6.39MShares$55.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.74MShares$41 Million0.0% of portfolio
-
State Street Corp Boston, MA3.07MShares$26.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$16.3 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA910KShares$7.87 Million0.32% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $673M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...